Baltimore Orioles pitcher Zach Eflin's career has been severely impacted by a series of unfortunate injuries over the past two seasons. After undergoing a lumbar microdiscectomy in 2025, which limited his play, he recently faced a more severe setback with a torn UCL, necessitating Tommy John surgery. This double blow has cast a shadow over his future with the team and in professional baseball, leading to deep personal disappointment for the athlete.
Eflin, a 6-foot-6, 230-pound right-hander, endured a particularly difficult 2025 season, making only 14 starts due to his back injury. The subsequent tear of his right ulnar collateral ligament (UCL) during his very first outing in 2026 was a devastating development. The recent Tommy John surgery, confirmed by The Baltimore Banner, means he will miss the remainder of the 2026 season, marking a significant and heartbreaking interruption to his professional trajectory.
Reflecting on the moment of his elbow injury, Eflin conveyed his profound emotional distress, stating that it felt as though his 'heart was ripped out of his chest.' This raw sentiment underscores the immense physical and mental toll that such severe injuries can take on professional athletes, particularly those who have dedicated years to their craft and are passionate about their sport.
The veteran pitcher's future with the Orioles is now a subject of considerable speculation. His current contract includes a mutual option for the 2027 season, valued at $25 million, as reported by Spotrac. This contractual detail adds an element of uncertainty to his long-term prospects, as both the player and the team will need to assess his recovery and potential effectiveness before making a decision on the option.
Before these recent setbacks, Eflin had a notable track record in the league. He joined the Orioles from the Tampa Bay Rays in July 2024, where he delivered a strong performance, achieving a 5-2 record with an impressive 2.60 ERA across nine starts. He also contributed during the playoffs, allowing only one run over four innings. In December, the Orioles re-signed him to a one-year, $10 million deal, with the aforementioned 2027 mutual option, demonstrating their initial confidence in his abilities.
Eflin's journey in baseball began with the Philadelphia Phillies, who called him up in 2016. He remained with the team until the 2022 campaign, notably recording a 3.38 ERA during 10 postseason appearances, culminating in the World Series where the Phillies ultimately fell to the Houston Astros. His performance peaked in 2023 after signing with the Rays, leading the American League with 16 wins over 31 starts, alongside a 3.50 ERA and a 1.02 WHIP, solidifying his reputation as a formidable pitcher.
With Eflin sidelined, the Orioles' pitching rotation will rely on a group including Trevor Rogers, Kyle Bradish, Shane Baz, Chris Bassitt, and Cade Povich. This shift highlights the team's depth and resilience in the face of key player injuries. The team is now preparing for an upcoming home series against the Arizona Diamondbacks, scheduled to begin on Monday at 6:35 p.m. ET.
The consecutive injuries to Zach Eflin have created a significant challenge for both the player and the Baltimore Orioles. While his past performances highlight his talent and potential, the road to recovery from Tommy John surgery is long and arduous. The mutual option in his contract for 2027 signifies a pivotal decision point that will shape his future in professional baseball, leaving many to wonder if he will be able to return to his previous form and once again dominate from the mound.
